Last updated on September 2017

OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension


Brief description of study

The objective of the study is to evaluate evaluate the safety and IOP lowering efficacy of OTX-TP, a sustained release travoprost drug product, placed in the canaliculus of the eyelid in the treatment of subjects with open-angle glaucoma or ocular hypertension

Clinical Study Identifier: NCT02914509

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Deepa Mulani

Artesia, CA United States
  Connect »

Deepa Mulani

Colorado Springs, CO United States
  Connect »

Deepa Mulani

Lakeland, FL United States
  Connect »

Deepa Mulani

Morrow, GA United States
  Connect »

Deepa Mulani

Shawnee, KS United States
  Connect »

Deepa Mulani

Des Peres, MO United States
  Connect »

Deepa Mulani

Rochester, NY United States
  Connect »

Deepa Mulani

Raleigh, NC United States
  Connect »

Deepa Mulani

Cincinnati, OH United States
  Connect »

Deepa Mulani

Austin, TX United States
  Connect »